Six-month randomized clinical trial comparing intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma

被引：3

|

作者：

Fellenbaum, PS

机构：

来源：

AMERICAN JOURNAL OF OPHTHALMOLOGY | 2003年 / 136卷 / 02期

关键词：

D O I：

10.1016/S0002-9394(03)00247-2

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

收藏

页码：392 / 392

页数：1

相关论文

共 50 条

[41] Comparison of the Efficacy of Latanoprost, Bimatoprost and Travoprost in Patients with Primary Open-Angle Glaucoma and Ocular Hypertension
Colak, Nur
Horozoglu, Fatih
TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2008, 38 (06): : 473 - 480
[42] A double-masked, randomized clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertension
Susanna, R
Giampani, J
Borges, AS
Vessani, RM
Jordao, MLS
OPHTHALMOLOGY, 2001, 108 (02) : 259 - 263
[43] The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension A 6-month, randomized, multicenter study
Michael Diestelhorst
Graefe's Archive for Clinical and Experimental Ophthalmology, 2000, 238 : 433 - 439
[44] The additive intraocular pressure-lowering effect of latanoprost 0.005% daily once and pilocarpine 2% t.i.d. in patients with open-angle glaucoma or ocular hypertension - A 6-month, randomized, multicenter study
Diestelhorst, M
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2000, 238 (05) : 433 - 439
[45] Comparison of the Efficacy of Latanoprost, Bimatoprost, and Travoprost in Patients with Primary Open-Angle Glaucoma and Ocular Hypertension
Colak, Nur
Yildirim, Aydin
Uslu, Hasim
Gurler, Bulent
TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2014, 44 (03): : 170 - 174
[46] IOP-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension
Cantor, LB
Hoop, J
Morgan, L
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
[47] COMPARISON OF THE IOP -LOWERING EFFICACY OF BIMATOPROST 0.03% AND TRAVOPROST 0.004% IN PATIENTS WITH GLAUCOMA OR OCULAR HYPERTENSION
L.B.Cantor
国际眼科杂志, 2003, (01) : 53 - 54
[48] Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on β-blockers -: Tolerance and peak Intraocular pressure lowering -: Discussion
Serle, JB
OPHTHALMOLOGY, 2002, 109 (02) : 314 - 315
[49] Prevalence of Ocular Surface Complaints in Patients With Glaucoma Using Topical Intraocular Pressure-Lowering Medications
Fechtner, Robert D.
Godfrey, David G.
Budenz, Donald
Stewart, Jeanette A.
Stewart, William C.
Jasek, Mark C.
CORNEA, 2010, 29 (06) : 618 - 621
[50] A pooled-data analysis of three randomized, double-masked, six-month clinical studies comparing the intraocular pressure reducing effect of latanoprost and timolol
Hedman, K
Alm, A
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2000, 10 (02) : 95 - 104

← 1 2 3 4 5 →